Opinion · 22 Oct 2024
Conference abstractPublished 2021
Generating real world evidence for regulators: the past, the present and the future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This keynote session will be divided into three sections: In the first part, a review of post authorization safety studies (PASS) from EU-PAS Register will be conducted. The characteristics of PASS in terms of the objectives (investigation of safety concerns, study of drug utilization, assessment of risk minimization measures, etc), the design (longitudinal, cross sectional), the data sources (primary, secondary), and the endpoints will be presented and compared between PASS registered from 2012 to 2015 and those conducted from 2015 to 2020. In a second part, an unpublished study of the interactions with the Pharmacovigilance Risk Assessment Committee (PRAC) over the protocol of 12 studies measuring risk minimization measures (RMMs) will be presented and the strategies for interacting with PRAC will be discussed. In the last part, the trends and perspectives for future of PASS will be presented and brief insights about these perspectives will be provided ot the audience. These include more involvement of different stakeholders, especially patients, in defining research questions, more systematic use of secondary data and data landscaping, increased integration of automation and common data models in evidence generation, and enhanced transparency requirements.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Massoud Toussi”
